Cardiology Flashcards
What disease accounts for 75% of cardiac cases in North America?
MMVD
What signalment of dog is more commonly affected with MMVD?
Males (1.5x), less than 20kg (85% show valve lesions by age 13)
What changes lead to progressive deformation of the valve structure in MMVD?
Dysregulation of the extracellular matrix
- Changes in collagen content and alignment of collagen fibrils
- Expansion of the spongiosa layer with changes in proteoglycans
Valvular interstitial cells aquire properties of activated myofibroblasts => increase in proteolytic enzymes (MMPs), which degrade collagen and elastin
What factors are moderately predictive of MMVD progression and can help identify dogs at risk for heart failure?
- Progressive enlargement of the LA and LV
- Increased transmitral E wave blood flow velocity
- Increased NT-proBNP
- Increased resting heart rate
What does the term heart failure refer to?
Clinical signs caused by heart dysfunction
What is “backward” heart failure?
- AKA congestive heart failure
- The heart fails to drain the veins adequately => increase in venous pressures => accumulation of fluid in the lungs or body cavities
What is “forward” heart failure?
- The heart’s pumping ability is compromised such that it cannot meet the body’s demands during exercise or at rest
- May or may not occur with backward heart failure
What is stage A MMVD?
Dogs at high risk for developing heart disease, but have no identifiable structural abnormalities (i.e. all Cavies without heart murmurs)
What is stage B MMVD?
Dogs with structural heart disease (murmur, etc) that have never developed clinical signs of heart failure
What is stage B1 MMVD?
Asymptomatic dogs with no radiographic or echocardiographic evidence of cardiac remodeling OR remodeling is present but mild (does not need criteria for treatment)
What is stage B2 MMVD?
- Asymptomatic dogs that have more advanced mitral regurgitation (hemodynamically severe) => radiographic and echocardiographic left atrial and ventricular enlargement
- Meet the criteria for treatment to delay the onset of CHF
What is stage C MMVD?
Dogs with current or past clinical signs of heart failure
What is stage D MMVD?
Dogs with end-stage MMVD - clinical signs of CHF are refractory to standard treatment and required advanced or specialized treatment strategies
How should patients with stage A MMVD be monitored?
Yearly physical examination with cardiac auscultation
If a murmur is identified during a routine examination, what diagnostics are always recommended?
- Thoracic radiographs - look for evidence of cardiac enlargement (use vertebral left atrial size) and establish a baseline for the patient’s appearance before CHF develops
- Blood pressure
- Echocardiogram, if possible
When should an echocardiogram be repeated in dogs with MMVD stage B1?
6-12 months (potentially more frequent in large breed dogs, as the disease progresses faster)
What are the criteria for meeting MMVD stage B2?
- Murmur greater than or equal to 3/6
- LA:Ao ratio in the right sided short axis view in early diastole >1.6
- Left ventricular internal diameter in diastole >1.7
- Breed adjusted VHS >10.5 (or greater than 11.5 if echo cannot be performed)
How is the vertebral left atrial score measured?
- Draw a line from the most ventral aspect of the carina to the the dorsal border of the caudal vena cava (the most caudal aspect of the LA)
- Transpose that line to the cranial edge of the 4th thoracic vertebral body
- > 3 likely = stage B2 MMVD
What are the treatment recommendations for MMVD stage B2?
- Pimobendan (0.25-0.3mg/kg PO q12)
- Mild dietary sodium restriction, highly palatable diet with adequate protein
- ACEi is recommended by 5/10 panelists
- Surgical valve repair can be considered
What two medications are currently not recommended for MMVD B2 patients?
Beta blockers, spironolactone - evidence is lacking
Name 3 potential complications of chronic mitral regurgitation
- Pulmonary hypertension
- Acquired atrial septal defect
- Pericardial effusion from an atrial tear
What dose of furosemide should be given to a hospitalized patient with CHF? When should it be repeated?
- 2mg/kg IV or IM
- Repeated doses of 2mg/kg hourly until the respiratory signs improve OR a total dose of 8mg/kg over 4 hours is reached
When should a furosemide CRI (1mg/kg/hr) be considered after the initial 2mg/kg bolus?
Life threatening pulmonary edema
- Expectoration of froth with severe dyspnea
- Radiographic “white out”
- Poor response to the initial furosemide bolus
Apart from furosemide, what other treatments are recommended for hospitalized patients with CHF?
- Pimobendan 0.25-0.3mg/kg q12
- Oxygen supplementation if needed
- Abdominocentesis or thoracocentesis, if needed
- Sedation to help with anxiety associated dyspnea (narcotics, anxiolytic agents)
- ACEi